Clinical Trials Browser

Phase 1/2 × Pancreatic Neoplasms × pegcetacoplan × Clear all

NCT07214298 2026-02-06

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Neoplasms